MX9307679A - Derivados de furanona utiles en terapia. - Google Patents

Derivados de furanona utiles en terapia.

Info

Publication number
MX9307679A
MX9307679A MX9307679A MX9307679A MX9307679A MX 9307679 A MX9307679 A MX 9307679A MX 9307679 A MX9307679 A MX 9307679A MX 9307679 A MX9307679 A MX 9307679A MX 9307679 A MX9307679 A MX 9307679A
Authority
MX
Mexico
Prior art keywords
therapy
furanone
useful
derivatives
formulations
Prior art date
Application number
MX9307679A
Other languages
English (en)
Inventor
Edwin Shen-Chou Wu
Alexander Kover
George Mullen
James Loch Iii
Original Assignee
Fisons Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929225498A external-priority patent/GB9225498D0/en
Priority claimed from GB929225497A external-priority patent/GB9225497D0/en
Priority claimed from GB939316531A external-priority patent/GB9316531D0/en
Application filed by Fisons Corp filed Critical Fisons Corp
Publication of MX9307679A publication Critical patent/MX9307679A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se relaciona con los derivados de furanona útiles en la terapia (en particular en el tratamiento de desórdenes neurodegenerativos), con los métodos para su uso, con las formulaciones que los incluyen y con los procesos para su producción.
MX9307679A 1992-12-05 1993-12-06 Derivados de furanona utiles en terapia. MX9307679A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929225498A GB9225498D0 (en) 1992-12-05 1992-12-05 Pharmacologically active compounds
GB929225497A GB9225497D0 (en) 1992-12-05 1992-12-05 Pharmacologically active compounds
GB939316531A GB9316531D0 (en) 1993-08-10 1993-08-10 Pharmacologically active compounds

Publications (1)

Publication Number Publication Date
MX9307679A true MX9307679A (es) 1994-06-30

Family

ID=27266497

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307679A MX9307679A (es) 1992-12-05 1993-12-06 Derivados de furanona utiles en terapia.

Country Status (10)

Country Link
EP (1) EP0672046A1 (es)
JP (1) JPH08503955A (es)
KR (1) KR950704322A (es)
AU (1) AU5655394A (es)
CA (1) CA2150947A1 (es)
FI (1) FI952733A (es)
IL (1) IL107881A0 (es)
MX (1) MX9307679A (es)
NO (1) NO952194D0 (es)
WO (1) WO1994013678A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU741566B2 (en) * 1997-01-27 2001-12-06 Warner-Lambert Company Single pot process for producing (Z)-azabicyclo oxime ethers
TWI243173B (en) * 1999-11-17 2005-11-11 Akzo Nobel Nv Spiro[2H-1-benzopyran-2,4'-piperidine] derivatives
DE602004010186T2 (de) * 2004-01-08 2008-07-03 F. Hoffmann-La Roche Ag Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075317A (en) * 1989-06-21 1991-12-24 Fisons Corporation Spirofurane derivatives
JPH03153690A (ja) * 1989-11-10 1991-07-01 Yamanouchi Pharmaceut Co Ltd ヘテロ環スピロ誘導体及びその製造法
IE914238A1 (en) * 1990-12-19 1992-07-01 Fisons Corp Novel spirofurane derivatives

Also Published As

Publication number Publication date
FI952733A0 (fi) 1995-06-05
AU5655394A (en) 1994-07-04
NO952194L (no) 1995-06-02
EP0672046A1 (en) 1995-09-20
JPH08503955A (ja) 1996-04-30
CA2150947A1 (en) 1994-06-23
KR950704322A (ko) 1995-11-17
IL107881A0 (en) 1994-04-12
WO1994013678A1 (en) 1994-06-23
FI952733A (fi) 1995-06-05
NO952194D0 (no) 1995-06-02

Similar Documents

Publication Publication Date Title
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
BR9305907A (pt) Uso de derivados de substituída para tratamento de esclerose múltipla
ES2102367T3 (es) Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
ES2058185T3 (es) Derivados de camptotecina y procedimiento para su preparacion.
ATE203751T1 (de) K-252a derivate, die neurotrophin-induzierte aktivität erhöhen
ECSP941104A (es) Derivados de 2,6 diaminopurina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
ES2070981T3 (es) Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo.
AR003220A1 (es) Derivados acilados de melatonina; composicion farmaceutica y cosmetica y el uso de los mismos para la preparacion de un medicamento.
MX9203653A (es) Composiciones amfotericas y formas polimericas de los alfa-hidroxiacidos.
MX9301348A (es) Nuevos compuestos que tienen actividad farmacologica, proceso para su preparacion y composicion farmaceutica que los comprende.
ITMI930699A1 (it) Derivati dell'indolo utili nel trattamento dei disturbi del sistema nervoso centrale
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
ES2063767T3 (es) Esteres aromaticos policiclicos de antibioticos macrolidicos y lincosamidicos, su procedimiento de preparacion y composiciones farmaceuticas y cosmeticas que los contienen.
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
ES2169037T3 (es) Conjugados polietilenglicol-hirudina, su procedimiento de preparacion y su empleo para el tratamiento de las trombosis.
ES2181702T3 (es) Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño.
ES2193248T3 (es) Antraquinonas mono- y disulfosustituidas y su uso para el tratamiento de desordenes de la matriz osea.
MX9301935A (es) Compuestos para el tratamiento de alteraciones neurodegenerativas.
MX9307679A (es) Derivados de furanona utiles en terapia.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
MX9401172A (es) Derivados fluorados de 4-aminoandrostadienona, procesamiento para su preparacion y composiciones farmaceuticas que los contienen.
FI954614A (fi) Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
MX9307048A (es) Derivados de piridazinoquinazolona, y composicion farmaceutica que los contiene.
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.